Skip Navigation
Skip to contents

Tuberc Respir Dis.  2011 May;70(5):371-383.

Pneumonia in Immunocompromised Patients

Affiliations
  • 1Division of Pulmonary Disease and Critical Care, Department of Internal Medicine, Youido St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea. cmcyhg@catholic.ac.kr

Abstract

The number of immunocompromised patients has increased over the past decades due to HIV infection, solid and stem cell transplantation, intensified chemotherapy and treatment of autoimmune disease. Pneumonia is a major cause of both morbidity and mortality in immunocompromised patients. Clinical management of pneumonia is difficult, since differential diagnosis in this setting is broad and includes both infectious and noninfectious processes. Because the development of pneumonia in immunocompromised patients is frequently life threatening, early therapeutic and diagnostic intervention is essential to obtain better outcomes.

Keyword

Pneumonia; Immunocompromised Patient; Disease Management

MeSH Terms

Autoimmune Diseases
Diagnosis, Differential
Disease Management
HIV Infections
Immunocompromised Host
Pneumonia
Stem Cell Transplantation
Full Text Links
  • TRD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr